Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1721-1722, 2001;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolthers, O. D.
Right arrow Articles by Heickendorff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolthers, O. D.
Right arrow Articles by Heickendorff, L.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1721-1722.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Diurnal Variations in Serum and Urine Markers of Type I and Type III Collagen Turnover in Children

Ole D. Wolthers1a, Carsten Heuck2 and Lene Heickendorff3

1 Children’s Clinic Randers, DK-8900 Randers, Denmark

2 Department of Paediatrics and Institute of Experimental Clinical Research, Medical Research Laboratories, and
3 Department of Clinical Biochemistry, Aarhus University Hospital, DK-8000, Aarhus, Denmark

aaddress correspondence to this author at: Children’s Clinic Randers, Dytmaersken 9, DK-8900 Randers, Denmark; fax 45-86-43-33-95, e-mail o.d.wolthers{at}dadlnet.dk

New serum and urine markers of type I and type III collagen turnover have recently been introduced in children. These markers include the formation markers of type I collagen turnover, serum N-terminal (PINP) and C-terminal (PICP) propeptides of type I procollagen, and serum N-terminal propeptide of type III procollagen (PIIINP), as well as the resorption markers serum cross-linked C-terminal telopeptide of type I collagen (ICTP) and urine cross-linked N-telopeptides of type I collagen (Ntx) and deoxypyridinoline (DPD) (1)(2)(3)(4)(5). The aim of the present study was to assess diurnal variations in serum PINP, PICP, ICTP, PIIINP, and urine DPD and Ntx in children.

Two boys and five girls 10.4–14.4 years (mean, 12.2 years) were studied. One boy and three girls were in puberty. Height SD scores varied from -2.5 to 2.2 (mean, 0.6) and weight SD scores from -1.4 to 1.0 (mean, -0.4). The study was approved by the local ethics committee, and informed consent was obtained from all children and their parents.

The first sample was urine collected from 2400 to 0800 on the morning of the day of investigation. Thereafter, urine was collected in 4-h intervals until 2400 and in another 8-h interval from 2400 to 0800. Blood samples were taken at 0900 and every 2 h thereafter until 0700 the following morning. The samples were centrifuged at 3000g for 10 min within 1 h after they were collected. After centrifugation, the samples were stored at -80 °C and batch-assayed at the completion of the study.

Each child received breakfast at 0815, lunch at 1300, an ice cream at 1630, and dinner at 1900. Sleep was permitted from 2400 to 0730.

Serum concentrations of PICP, PINP, ICTP, and PIIINP were determined by specific RIAs based on human antigen (Orion Diagnostica) (1)(2)(3). Intra- and interassay variations were 3.5–3.9% and 4.1–7.2%, respectively. Urine DPD was measured by a solid-phase chemiluminescent enzyme immunoassay on an automated instrument (Immulite Pyrilinks-D; Diagnostica Products Corporation) (4). Urine Ntx was measured by the Osteomark immunoassay (Ostex) (5). Intra- and interassay variations were 8% and 9% for the DPD assay, respectively, and 8% and 12% for the Ntx assay, respectively.

Data are described as percentages of the overall day mean ± SE of the mean in the 24-h profile. To evaluate the 24-h profiles one-way ANOVA for repeated measurements was performed followed by the Student-Newman-Keuls method for all pairwise multiple comparisons. The 5% level of significance was used.

PICP and ICTP were relatively low during the day (Fig. 1 ) with increased PICP concentrations from 0100 to 0500 (P = 0.006; F = 5.0) and ICTP concentrations from 0100 to 0700 (P = 0.002; F = 6.2). Peak concentrations of PICP (mean ± SE) occurred at 0500 [342.0 µg/L (91.6 µg/L)] and trough concentrations at 1100 [286.0 µg/L (46.4 µg/L); P = 0.01]. Peak concentrations of ICTP were detected at 0700 [12.1 µg/L (1.4 µg/L)] and trough concentrations at 2100 [10.3 µg/L (1.3 µg/L); P = 0.02]. No significant variations in PINP (F = 2.1; P = 0.17) or PIIINP (F = 2.1; P = 0.15) were detected.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1. Mean ± SE 24-h profiles of serum PICP, PINP, ICTP, and PIIINP and 32-h profiles of urine DPD and Ntx (standardized for creatinine) in seven healthy children expressed as percentages of the overall day mean.

A significant diurnal variation in urine DPD (F = 15.1; P <0.001) and Ntx (F = 8.2; P <0.001) was found. Peak concentrations of DPD occurred in urine collected at 0800–1200 [19.7 nmol/mmol (1.6 nmol/mmol)] and trough concentrations in urine collected at 2000–2400 [12.4 nmol/mmol (1.0 nmol/mmol); P <0.01]. DPD in the urine collected at 0800–1200 and two samples collected at 2400–0800 did not vary, whereas DPD concentrations in each of these periods were higher than in the samples collected at 1200–1600, 1600–2000, and 2000–2400 (P <0.05 for all comparisons). Peak concentrations of Ntx were found during the second 2400–0800 sampling [1323.3 (134.4) nmol/mmol] and trough concentrations during the 2000–2400 time period [812.1 (98.8) nmol/mmol; P <0.01]. Ntx in both samples collected at 2400–0800 were higher than in the samples collected at 1200–1600, 1600–2000, and 2000–2400 (P <0.05 for all comparisons).

Considering the marked diurnal variations in PICP and ICTP, it may be difficult to interpret the finding of no rhymicity in PINP concentrations. There are no available data in adults or in children for comparison of the finding. Perhaps differences in assay sensitivity and metabolism of the propeptides may play a role, necessitating a larger study population than the present to detect possible variations in PINP. Our observation of no diurnal variation in PIIINP concentrations, however, is in accord with a previous report in children (1).

Using an immunoassay, a study of a group of healthy girls, 10–14 years of age, revealed nocturnal peak concentrations of DPD at 0300 and trough concentrations at 1300 (6). The findings are in accord with observations of adults based on immunoassay (7) and HPLC (8) for assessment of total DPD. Furthermore, our results obtained by an immunoassay that specifically measures the free fraction of DPD are consistent with the findings of Robins et al. (4). One study using HPLC, however, found a statistically significant circadian variation only in total, not in free, DPD (9), thus supporting suggestions that in adults, diurnal variations in free DPD may be less marked than in total DPD. Whether this may reflect that the ratio between free and total DPD may vary between children and adults is unclear. Furthermore, the present finding of diurnal variations in Ntx corrected for creatinine is in accord with studies in adults (10). However, when Ntx was not corrected for creatinine in adults, a circadian variation could not be detected. To what extent diurnal variations in DPD and Ntx in children may depend on variations in creatinine needs further study.


References

  1. Saggese G, Baroncelli I, Bertelloni S, Cinquanta L, Dinero G. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr Res 1994;35:409-415.[Web of Science][Medline] [Order article via Infotrieve]
  2. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996;42:947-954.[Abstract/Free Full Text]
  3. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-640.[Abstract/Free Full Text]
  4. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-1649.[Web of Science][Medline] [Order article via Infotrieve]
  5. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-1258.[Web of Science][Medline] [Order article via Infotrieve]
  6. Eastell R, Simmons PS, Colwell A, Assire AM, Burritt MF, Russell RG, Riggs BL. Nyctohemeral changes in bone turnover assessed by serum Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and aging. Clin Sci 1992;83:375-382.[Medline] [Order article via Infotrieve]
  7. Aoshima H, Kushida K, Takahashi M, Ohishi T, Hoshino H, Inoue T. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998;22:73-78.[Medline] [Order article via Infotrieve]
  8. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. The effect of calcium supplementation on circadian rhythm of bone resorption. J Clin Endocrinol Metab 1994;79:730-735.[Abstract]
  9. Calabresi E, Lasagni L, Franceschelli F, de Leonardis V, Becorpi A, Serio M, et al. Comparison of immuno- and HPLC-assays for the measurement of urinary cross-links. J Endocrinol Invest 1994;17:625-629.[Web of Science][Medline] [Order article via Infotrieve]
  10. Ju HSJ, Leung S, Brown B, Stringer MA, Leigh S, Scherer C, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:1570-1576.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
T. V. Nguyen, A. E. Nelson, C. J. Howe, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, and K. K. Ho
Within-Subject Variability and Analytic Imprecision of Insulinlike Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests
Clin. Chem., August 1, 2008; 54(8): 1268 - 1276.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolthers, O. D.
Right arrow Articles by Heickendorff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolthers, O. D.
Right arrow Articles by Heickendorff, L.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS